title: Neurometabolic disease: Treating mitochondrial diseases with mTOR inhibitors--a potential treatment for Leigh syndrome?
authors.forename: Tim
authors.initials: T
authors.lastname: Geach
mesh_terms: D000818:Animals; D007888:Leigh Disease / Q000188:drug therapy*; D028361:Mitochondrial Diseases / Q000188:drug therapy*; D058990:Molecular Targeted Therapy; D046912:Multiprotein Complexes / Q000037:antagonists & inhibitors*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D020123:Sirolimus / Q000627:therapeutic use*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D046912:Multiprotein Complexes; D018696:Neuroprotective Agents; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus